MEDIPHARM ANDERLECHT
ActiveSummary
The computed 12-month bankruptcy probability of MEDIPHARM ANDERLECHT is 2.1% (moderate). The 2025 annual accounts show equity of €17,978 and a net result of €32,003. Equity remains stable across the filed financial years (±1.8% per year). Its solvency ranks better than 26% of 22,650 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21372D0180/00V003 | Brussels | 215 m² | 1 · 58 m² | 9.3 m · 3 |